This trial is a pilot RCT to study the efficacy of 2 types of venous cannulation during surgery for CABG in reducing the incidence of AF. 40 patients will be included, with 20 in each group. The primary endpoint is any episode of AF lasting >5 minutes or any episode leading to hemodynamic compromise or symptoms. Patients will be followed up at 1 month.
1 Primary · 3 Secondary · Reporting Duration: During hospital admission and clinic visit at 30 days from hospital discharge date.
Active Control
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: Bicaval cannulation · No Placebo Group · N/A
Age 18 - 100 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: